June 17, 2013

Astra back in obesity with early NGM deal

May 07, 2013

Lipodystrophy could give metreleptin a new lease of life

February 12, 2013

Average M&A deal values fall back in 2012

February 07, 2013

M&A activity cools in 2012 as break-ups loom

January 24, 2013

Vantage Point – Stars align for AstraZeneca to team up with Bristol for Shire swoop

January 22, 2013

Biotech still relying on friends for financing in 2012

January 03, 2013

Deals over the Christmas period

November 19, 2012

VC dollars rain onto Intarcia on diabetes implant hopes

August 30, 2012

Effient failure illustrates the perils of head-to-head trials

Eli Lilly finds Effient is not flattered by comparison in Trilogy ASC trial.